Veracyte (VCYT) EBT (2012 - 2026)

Veracyte (VCYT) has 15 years of EBT data on file, last reported at $30.0 million in Q1 2026.

• Quarterly EBT rose 303.53% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.7 million (up 158.68% YoY) and the FY2025 annual result came in at $68.2 million, up 164.92% from the prior year.
• EBT declined to $30.0 million in Q1 2026 per VCYT's latest filing, from $40.6 million in the prior quarter.
• The five-year high for EBT was $40.6 million in Q4 2025, with the low at -$30.5 million in Q4 2023.
• Average EBT over 5 years is $642235.3, with a median of -$1.9 million recorded in 2024.
• Year-over-year, EBT plunged 792.21% in 2023 and soared 1080.16% in 2025.
• Veracyte's EBT stood at -$3.4 million in 2022, then plunged by 792.21% to -$30.5 million in 2023, then jumped by 111.3% to $3.4 million in 2024, then soared by 1080.16% to $40.6 million in 2025, then decreased by 26.23% to $30.0 million in 2026.
• Business Quant data shows VCYT's EBT at $30.0 million in Q1 2026, $40.6 million in Q4 2025, and $18.9 million in Q3 2025.